Article Details
Retrieved on: 2025-04-12 20:30:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses studies signaling GLP-1 receptor agonists, like Ozempic and tirzepatide, may lower dementia risk, including Alzheimer's. These drugs, primarily used for type 2 diabetes and obesity, show potential in aging-associated diseases.
Article found on: www.foxnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here